Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FVLZ1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,103
Award facts
- Contract value 100% obligated
- $44,103.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,103.30 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 (60-count units), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price, competitively awarded contract was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle enabling the company to supply medications and medical supplies to military healthcare systems globally.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contracts with the DLA Medical Supply Chain, delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical contract provides AmerisourceBergen with the flexibility to fulfill pharmaceutical requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order represents a routine fulfillment of military healthcare pharmaceutical needs, consistent with the company's established role as a primary vendor within the DLA's pharmaceutical supply chain supporting military medical operations worldwide.
Quick answers
Who was awarded contract SPE2DB25FVLZ1?
SPE2DB25FVLZ1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FVLZ1 worth?
The government has obligated $44,103 on SPE2DB25FVLZ1.
Is contract SPE2DB25FVLZ1 an order under another contract?
Yes. SPE2DB25FVLZ1 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVLZ1 competed?
The extent of competition for SPE2DB25FVLZ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award